Washburn Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Washburn Capital Management's LLY Position: Q2 2026 in Review
Washburn Capital Management reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $188K and leaving 842 shares worth $1.01M. The position accounts for 0.5% of the portfolio, ranked #31.
Washburn Capital Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.53M in Q2 2024. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Washburn Capital Management held 842 shares of Eli Lilly worth $1.01M as of Q2 2026.
- Washburn Capital Management sold 184 Eli Lilly shares in Q2 2026, an estimated $188K.
- Eli Lilly made up 0.5% of Washburn Capital Management's portfolio in Q2 2026, its #31 holding.
- Washburn Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- Washburn Capital Management's Eli Lilly position peaked at $2.53M in Q2 2024.
- 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Washburn Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.